Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation.
M Y Aksenov; M V Aksenova; D A Butterfield; K Hensley; C Vigo-Pelfrey; J M Carney (Profiled Author: Butterfield, D Allan)
Department of Pharmacology, University of Kentucky, Lexington 40536, USA.
Journal of neurochemistry 1996;66(5):2050-6.
beta-Amyloid peptide (A beta) is the main constituent in both senile plaques and diffuse deposits in Alzheimer's diseased brains. It was previously shown that synthetic A beta s were able to form free radical species in aqueous solution and cause both oxidative damage to cell proteins and inactivation of key metabolic enzymes. We also previously demonstrated that an interaction of A beta (1-40) with the oxidatively sensitive enzyme glutamine synthetase (GS) resulted in both inactivation of GS and an increase of A beta toxicity to hippocampal cell cultures. In the present study the enhancement of A beta toxicity during interaction with GS was found to be accompanied by abrogation of fibril formation and partial fragmentation of A beta (1-40). HPLC elution profiles demonstrated the production of several peptide fragments. Analysis of the amino acid sequence of the major fragments identified them as the first 15 and the last six amino acids of A beta (1-40). The fragmentation of A beta was inhibited by immunoprecipitation of GS.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Grants
-
1.
TEPLOW, DAVID B.
Physical Biochemistry and Biology of Amyloid Beta-Protein
15 September 2011 - 31 August 2016
NATIONAL INSTITUTE ON AGING
Total Funding: $ 315,700
-
2.
TEPLOW, DAVID B.
Structural Biology of Amyloid Beta-Protein
10 December 1998 - 28 February 2015
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 3,930,754
-
3.
MUFSON, ELLIOTT JAY
Galanin in Alzheimer's Disease
29 September 1991 - 31 May 2012
NATIONAL INSTITUTE ON AGING
Total Funding: $ 5,750,823
Related Publications
-
1.
1995Aksenov MYu; M V Aksenova; M E Harris; K Hensley; D A Butterfield; J M Carney
Enhancement of beta-amyloid peptide A beta(1-40)-mediated neurotoxicity by glutamine synthetase.
Journal of neurochemistry 1995;65(4):1899-902. -
2.
1997M Y Aksenov; M V Aksenova; J M Carney; D A Butterfield
Oxidative modification of glutamine synthetase by amyloid beta peptide.
Free radical research 1997;27(3):267-81. -
3.
1995K Hensley; D A Butterfield; M Mattson; M Aksenova; M Harris; J F Wu; R Floyd; J Carney
Proceedings of the Western Pharmacology Society 1995;38():113-20.
Related Topics
Appears in this Publication
-
-
-
-
-
-
Amyloid beta-Protein Precurs...
-
-
-
-
-
-
-
High Pressure Liquid Chromat...
-
Enzyme-Linked Immunosorbent ...
-
Electrophoresis, Polyacrylam...
-
-
-
-
-
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
439









-
377









-
667









-
411









-
672









-
779









